SYNERON MEDICAL LTD - ORD SHS (ELOS)

CUSIP: M87245102

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / ORD SHS
Total 13F shares
22,784,637
Share change
+25,885
Total reported value
$280,228,203
Price per share
$12.30
Number of holders
67
Value change
+$318,035
Number of buys
1
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q4 2013

As of 31 Dec 2013, SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,784,637 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, Visium Asset Management, LP, JPMORGAN CHASE & CO, NORTH TIDE CAPITAL, LLC, BRANDES INVESTMENT PARTNERS, LP, ROYCE & ASSOCIATES LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, HOURGLASS CAPITAL, LLC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., and RENAISSANCE TECHNOLOGIES LLC. This page lists 67 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.